Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Sell
54,593
-4,590
-8% -$201K 0.04% 388
2026
Q1
$2.78M Sell
59,183
-18,224
-24% -$714K 0.06% 285
2025
Q4
$2.69M Buy
77,407
+55,834
+259% +$1.96M 0.06% 288
2025
Q3
$743K Sell
21,573
-10,674
-33% -$358K 0.02% 433
2025
Q2
$965K Buy
32,247
+24,242
+303% +$711K 0.03% 411
2025
Q1
$270K Sell
8,005
-8,561
-52% -$279K 0.02% 447
2024
Q4
$490K Buy
+16,566
New +$498K 0.03% 373

Other funds holding BP

Callan Family Office's BP Position: Q2 2026 in Review

Callan Family Office reduced its BP (BP) stake by 7.8% in Q2 2026, selling an estimated $201K and leaving 54,593 shares worth $2.02M. The position accounts for 0.04% of the portfolio, ranked #388.

Callan Family Office first reported a position in BP in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.78M in Q1 2026. 1,171 funds tracked by Wall St. Rank hold BP as of Q2 2026.

  • Callan Family Office held 54,593 shares of BP worth $2.02M as of Q2 2026.
  • Callan Family Office sold 4,590 BP shares in Q2 2026, an estimated $201K.
  • BP made up 0.04% of Callan Family Office's portfolio in Q2 2026, its #388 holding.
  • Callan Family Office first reported a position in BP in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's BP position peaked at $2.78M in Q1 2026.
  • 1,171 funds tracked by Wall St. Rank held BP as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.